Nidocard Retard Tablet 6.4 mg contains Nitroglycerin, a potent long-acting nitrate used for the prevention and management of angina pectoris (chest pain caused by reduced blood flow to the heart). This sustained-release formulation is specifically designed to provide extended cardiovascular protection, ensuring stable plasma levels of nitroglycerin over a longer period compared to immediate-release tablets.

Nitroglycerin works by relaxing vascular smooth muscles, especially in veins and coronary arteries. This vasodilation decreases the preload and afterload on the heart, reducing myocardial oxygen demand and helping prevent ischemic episodes. The sustained-release mechanism of Nidocard Retard 6.4 mg ensures gradual absorption, which maintains consistent therapeutic effects, minimizes the frequency of angina attacks, and reduces the need for multiple daily doses.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Nidocard Retard Tablet 6.4 mg is indicated for:

• Chronic stable angina: For long-term prevention of recurrent chest pain in patients with coronary artery disease

• Prophylaxis prior to physical exertion: Reduces the risk of exertional angina episodes

• Adjunct therapy in ischemic heart disease: Used in combination with other anti-anginal medications to optimize heart protection

• Long-term management of coronary artery disease: Helps maintain consistent symptom control and improve patient quality of life

This formulation is intended for adult patients with chronic angina, prescribed under the guidance of a healthcare professional.

Key Benefits

• Prolonged angina prevention: Provides sustained relief from chest pain for 12–24 hours

• Reduces cardiac workload: Lowers oxygen demand by dilating veins and arteries

• Improves exercise tolerance: Helps patients engage in daily activities with fewer angina episodes

• Convenient dosing: Once- or twice-daily administration enhances adherence to therapy

• Stable therapeutic effect: Sustained-release formulation maintains consistent blood levels, minimizing fluctuations and breakthrough angina

Nidocard Retard 6.4 mg offers a reliable and effective solution for long-term management of angina, supporting heart health while reducing the risk of ischemic events.

Dosage and Administration

• The usual starting dose is 6.4 mg once daily, preferably in the morning; dosage adjustments are made according to patient response and tolerance

• Swallow the tablet whole with water; do not crush, chew, or break

• Take at the same time each day to maintain steady plasma levels

• Avoid sudden discontinuation, as this may lead to recurrence of angina

• Can be used in combination with other anti-anginal agents as prescribed

Dosage must be individualized based on patient condition, symptom severity, and concurrent medications.

Precautions

• Use with caution in patients with hypotension, severe anemia, or increased intracranial pressure

• Avoid concurrent use with phosphodiesterase inhibitors (e.g., sildenafil, tadalafil) due to the risk of severe hypotension

• Monitor blood pressure regularly, particularly during initiation or dose adjustments

• Use in pregnancy or breastfeeding only under medical supervision

• Inform the physician about all medications to prevent potential drug interactions

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Nidocard Retard Tablet 6.4 mg is generally well tolerated. Common side effects may include:

• Headache, especially early in therapy

• Dizziness or lightheadedness

• Flushing or warmth of the face

• Rare: hypotension, fainting, or reflex tachycardia

Most adverse effects are mild, transient, and often decrease with continued use or dose adjustment.

Storage Instructions

• Store in a cool, dry place below 25°C, protected from light and moisture

• Keep tablets in their original packaging until use

• Keep out of reach of children

• Do not use after the expiration date

Nidocard Retard Tablet 6.4 mg (Nitroglycerin) provides effective, long-lasting prevention of angina, reducing cardiac stress and improving the overall quality of life for patients with chronic coronary artery disease.